International Society for Antiviral Research

International Society for Antiviral Research (ICAR)
Formation1987; 37 years ago (1987)
TypeScientific society
HeadquartersLogan, Utah[1]
Location
  • United States
Membership
>400
President of the International Society for Antiviral Research
Luis M Schang
Key people
President-elect David Durantel
Websitewww.isar-icar.com

The International Society for Antiviral Research (ISAR) is a scientific society that focuses on the discovery and clinical application of antiviral agents. It was founded in 1987 to encourage the exchange of information and collaborative research on the development of biological, and chemical antiviral agents.

ISAR sponsors the International Conference on Antiviral Research (ICAR), held yearly since 1988 when the second ICAR occurred in Williamsburg, Virginia. ISAR also provides scientific information through peer-reviewed scientific journals and administers several international awards.[2]

As of May 25, 2024, the president of the society was Luis M Schang and the president-elect was David Durantel.[3] Previously, Johan Neyts was president from 2018-2020, succeeded as president by Kara Carter (2020-2022), and then Katherine Seley-Radtke (2022-2024).[4][5]

Founding

[edit]

The foundation for the International Society for Antiviral Research (ISAR) was laid at meetings held in Rotterdam, Netherlands (April 30 – May 3, 1985)[2]: 3, 23, 51  and in Il Ciocco, Italy (May 10-23, 1987) by NATO.[6]: 37  The society, in the persons of William M. Shannon, Earl R. Kern, and Richard J. Whitley registered articles of incorporation in the United States in the state of Alabama, on May 14, 1987.[7]: 6–7  The society's stated purpose was "the promotion and advancement of scientific knowledge in the area of antiviral scientific research for the benefit of all human beings".[7]

The original Board of Directors of ISAR included Alfons Billiau (KU Leuven, Leuven, Belgium), Erik De Clercq (Rega Institute, KU Leuven), A. Kirk Field (Squibb Institute for Medical Research, Princeton, New Jersey), George J. Galasso (National Institutes of Health (U.S.)), Earl R. Kern (University of Utah, Salt Lake City, Utah), William M. Shannon (Southern Research Institute, Birmingham, Alabama), and Richard J. Whitley (University of Alabama at Birmingham).[7][8] Richard Whitley became the first president of ISAR, serving from 1988-1990, with De Clercq as president elect.[8]

Conferences

[edit]

The International Conference on Antiviral Research (ICAR) has been held every year since 1988. Its location circulates between the United States, Europe, and the rest of the world, reflecting the distribution of its members.[9] The last annual meeting, 37th ICAR was held in Gold Coast, Australia, May 20-24, 22024. The next annual meeting, 38th ICAR, will be held in March 13-17, 2025 in Las Vegas, NV, USA.

It is generally agreed that the second ICAR was a meeting held in Williamsburg, Virginia in 1988, which was advertised as such.[2]: 3, 23 

Neither the Rotterdam meeting (1985) nor the Italy meeting (1987) was identified at the time as "the first" International Conference for Antiviral Research (ICAR). Since then, each meeting has been described as the first ICAR meeting by different proponents.[2]: 3, 23  George Galasso and others consider Rotterdam the first meeting because at that meeting Galasso, Erik De Clercq and Alfons Billiau discussed formation of a Society and decided to approach Earl Kern and Richard Whitley. Erik De Clercq has emphasized the 1987 NATO meeting at Il Ciocco because ideas for both ISAR and ICAR were developed there.[2]: 3, 23 

Publications

[edit]

Awards given

[edit]

Presidents

[edit]

References

[edit]
  1. ^ Cumulative List of Organizations Described in Section 170 (c) of the Internal Revenue Code of 1986. Vol. 2. Department of the Treasury, Internal Revenue Service. 1997. p. 268.
  2. ^ a b c d e f g h i j k l m n o p q Vere Hodge, R. Anthony, ed. (2019). The International Society for Antiviral Research: The Third Decade 2008-2017 (PDF). International Society for Antiviral Research.
  3. ^ "NOTICE FROM ISAR: ICAR2024". International Society for antiviral research. 2024. Retrieved 26 May 2024.
  4. ^ a b c d "ISAR Officers". International Society for antiviral research. Retrieved 12 May 2020.
  5. ^ a b Seley-Radtke, Katherine (May 10, 2020). "Remdesivir explained – what makes this drug work against viruses?". The Street. Retrieved 12 May 2020.
  6. ^ "Report on the 25th ICAR, 16–19 April 2012, Sapporo, Japan". Antiviral Chemistry and Chemotherapy. 23 (1): 35–43. August 2012. doi:10.3851/IMP2385. S2CID 207964758.
  7. ^ a b c d e The International Society for Antiviral Research: The First Decade 1987-1997 (PDF). International Society for Antiviral Research. 1998.
  8. ^ a b Colacino, Joseph M. (April 2013). "Professor De Clercq and 25 Years of International Collaboration on Antiviral Research". Antiviral Chemistry and Chemotherapy. 23 (2): 57–58. doi:10.3851/IMP2395. PMID 22992324. S2CID 207735250.
  9. ^ a b De Clercq, Erik (2016). "ICAR THROUGH THE YEARS" (PDF). ISAR NEWS (Newsletter of the International Society for Antiviral Research). 25 (3): 16–18. Retrieved 26 May 2024.
  10. ^ "Antiviral Research". Microsoft Academic. Retrieved 12 May 2020.[dead link]
  11. ^ Field, Hugh J. (February 2015). "AVCC 1990–2015 – A journal to combine antiviral biology and antiviral chemistry enters the third era". Antiviral Chemistry and Chemotherapy. 24 (1): 1–2. doi:10.1177/2040206615574801. PMC 5890501. PMID 26149261.
  12. ^ a b c d e Shannon, William M., ed. (2008). The International Society for Antiviral Research: The Second Decade 1998-2007 (PDF). International Society for Antiviral Research.[permanent dead link]
  13. ^ "Professor Griffiths receives Gertrude Elion Memorial Award". University College London. 23 March 2018. Retrieved 12 May 2020.
  14. ^ a b c d e "ISAR presents the following awards and opportunities as listed below". International Society for Antiviral Research. Retrieved 12 May 2020.
  15. ^ "Gertrude Elion Memorial Award". isar-icar.com. Retrieved 2024-03-21.
  16. ^ "William H. Prusoff, Ph.D". Yale Medicine Magazine. Yale University. 2001. Retrieved 12 May 2020.
  17. ^ "Piet Herdewijn receives Antonin Holý Memorial Lecture award May 2014". Rega Institute KU Leuven. 2014. Retrieved 12 May 2020.
  18. ^ a b Vere Hodge, R. Anthony (28 June 2018). "Meeting report: 30th International Conference on Antiviral Research, in Atlanta, GA, USA". Antiviral Chemistry and Chemotherapy. 26: 204020661878392. doi:10.1177/2040206618783924. PMC 6043914. PMID 29954186.
  19. ^ "Richard J. Whitley". University of Alabama at Birmingham School of Medicine. Retrieved 12 May 2020.
  20. ^ "John C. Martin. Ph.D., MBA". The University of Alabama at Birmingham. Retrieved 12 May 2020.[permanent dead link]
  21. ^ Jung, Rhonda (November 13, 2006). "Southern Research Institute CEO Jack Secrist Recognized For Contributions In Cancer Drug Research". BioSpace. Retrieved 12 May 2020.
  22. ^ "Genelabs Appoints Amy K. Patick, Ph.D. Vice President, Biological Sciences". BusinessWire. April 14, 2008. Retrieved 12 May 2020.
  23. ^ "PTC Therapeutics expands management team". PTC Therapeutics. Jan 24, 2014. Retrieved 12 May 2020.
  24. ^ "Phillip A. Furman". Florida Inventors Hall of Fame. 10 April 2018. Retrieved 12 May 2020.
  25. ^ "Immune Therapeutics, Inc. Announces Advisory Board Appointments". GlobeNewsWire (Press release). October 22, 2019. Retrieved 12 May 2020.
  26. ^ "5th IAAASS 2020 CONFIRMED SPEAKERS". 5th IAAASS 2020. Retrieved 12 May 2020.
  27. ^ "Interview: Belgian virologist calls for global efforts against new viruses". Xinhua. 2020-02-07. Retrieved 12 May 2020.[dead link]
Retrieved from "https://en.wikipedia.org/w/index.php?title=International_Society_for_Antiviral_Research&oldid=1232811494"